StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health CarelonRx by Quarter

CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M)

Elevance Health CarelonRx: $10,779M in Q3 2026, up 5.6% from a year earlier. That is the highest of the 11 quarters on record here.

Latest, Q3 2026
10,779
Period ended Sep 30, 2026
Change on a year earlier
+5.6%
10,209 in Q3 2025
History
11 quarters
Since Q1 2024
Sources
8
Documents cited below

Where the Q3 2026 figure comes from

“|| Cost of products sold | — | 10,779 | — | 10,779 | — | ( 5,139 ) | 5,640”

Source: 10-Q (2026-10-21) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M)Year on yearSource
Q3 2026Sep 30, 202610,779+5.6%10-Q (2026-10-21) ↗
Q2 2026Jun 30, 202610,473+6.0%10-Q (2026-07-15) ↗
Q1 2026Mar 31, 20269,830+5.9%10-Q (2026-04-22) ↗
Q4 2025Dec 31, 202510,700+15.9%Derived Q4 = FY2025 (10-K (FY2025, 2026-02-06)) − 9M2025 (10-Q (2026-10-21)) ↗
Q3 2025Sep 30, 202510,209+22.5%10-Q (2026-10-21) ↗
Q2 2025Jun 30, 20259,884+22.9%10-Q (2026-07-15) ↗
Q1 2025Mar 31, 20259,284+25.9%10-Q (2026-04-22) ↗
Q4 2024Dec 31, 20249,229–Derived Q4 = FY2024 (10-K (FY2025, 2026-02-06)) − 9M2024 (10-Q (2025-10-21)) ↗
Q3 2024Sep 30, 20248,336–10-Q (2025-10-21) ↗
Q2 2024Jun 30, 20248,040–10-Q (2025-07-17) ↗
Q1 2024Mar 31, 20247,373–10-Q (2025-04-22) ↗

Cite this data

StockData. (2026). Elevance Health CarelonRx ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg-carelonrx-cost-of-products

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.